Medical/Pharmaceuticals
Well Begun AND Half Done! - SIRONA Randomized Trial Achieves fifty percent enrollment
JENA, Germany, Feb. 10, 2022 /PRNewswire/ -- Concept Medical Inc.,
2022-02-10 08:21
3740
USI Awarded S&P Global Bronze Class in Sustainability Yearbook 2022
SHANGHAI, Feb. 10, 2022 /PRNewswire/ -- USI (SSE: 601231) is pleased to announce the recognition as a S&P Global Bronze Class company in our first invited participation of the S&P Global ESG Index Corporate Sustainability Assessment (CSA). The Sustainability Yearbook 2022 is based on the 2021 CSA...
2022-02-10 07:00
5697
Correction: Year-end report 2021 Bactiguard Holding AB
STOCKHOLM, Feb. 9, 2022 /PRNewswire/ -- In previous press releases regarding the year-end report for 2021, incorrect information related to "Cash flow from operating activities" has been reported. Correction is made with this press release and the correct PDF is attached for Bactiguard Holding AB...
2022-02-09 22:17
3146
X-Chem and Excelra's GOSTAR Join Forces to Advance Drug Discovery for Challenging Targets
LONDON and HYDERABAD, India, Feb. 9, 2022 /PRNewswire/ -- A new collaboration between data science and analytics leader, Excelra, and artificial intelligence pioneer X-Chem will accelerate preclinical drug discovery and aid scientists to find new drug candidates for currently hard-to-drug targets...
2022-02-09 22:00
4512
Sirtex Medical and Grand Pharmaceutical Group Limited receive NDA approval of SIR-Spheres® Y-90 resin microspheres in China from the National Medical Products Administration
SIR-Spheres® Y-90 resin microspheres are the first therapeutic radiopharmaceutical approved by the NMPA in 2022 WOBURN, Mass., Feb. 9, 2022 /PRNewswire/ -- Sirtex Medical ("Sirtex"), a leading manufacturer of targeted liver cancer therapies, announced today with its shareholder, Grand Pharmaceut...
2022-02-09 21:30
2251
Angel Yeast's Patented Probiotic S. boulardii Alleviates Common IBD Symptoms, New Research Shows
YICHANG, China, Feb. 9, 2022 /PRNewswire/ -- Angel Yeast Co., Ltd
2022-02-09 21:00
3704
Mobile Medical Imaging Systems Improving Care Accessibility and Convenience for Patients
Portability and cost-effectiveness are key factors propelling the adoption of mobile medical imaging technology globally, says Frost & Sullivan SAN ANTONIO, Feb. 9, 2022 /PRNewswire/ -- Frost & Sullivan's recent analysis finds that the drawbacks of traditional medical imaging platforms are drivin...
2022-02-09 20:00
2044
Sirnaomics Launches Phase I Clinical Trial of RNAi Therapeutic STP707 Delivered Systemically for the Treatment of Solid Tumors
HONG KONG, Feb. 9, 2022 /PRNewswire/ -- Sirnaomics Ltd. (the "Company" or "Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced the start of a Phase I clinical trial for evaluation of the safety, tolerability and anti-...
2022-02-09 17:12
2316
Sirnaomics Launches Phase I Clinical Trial of RNAi Therapeutic STP707 Delivered Systemically for the Treatment of Solid Tumors
HONG KONG, Feb. 9, 2022 /PRNewswire/ -- Sirnaomics Ltd. (the "Company" or "Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, announced the start of a Phase I clinical trial for evaluation of the safety, tolerability and anti-...
2022-02-09 17:10
2802
Hummingbird Bioscience Publishes Preclinical Data Demonstrating Therapeutic Potential of HMBD-002 in VISTA-expressing Cancers
HOUSTON and SINGAPORE, Feb. 9, 2022 /PRNewswire/ -- Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets in cancer and autoimmune disease, today announced the publication of preclinical data for HMBD-002, a nov...
2022-02-09 17:00
2344
Glenmark and SaNOtize announce positive Results from Phase 3 Clinical Trial of NONS (FabiSpray®) in Non-Hospitalized Adult Indian Patients with COVID-19
* Phase 3 trial in India met the key endpoints and demonstrated reduction of viral load of 94% in 24 hours and 99% in 48 hours. * NONS was safe and well tolerated in COVID-19 patients. * Glenmark received manufacturing and marketing approval from India's drug regulator for Nitric Oxide Nasal...
2022-02-09 15:47
3408
COLOPLAST SINGAPORE LAUNCHES SENSURA MIO(R), A PRODUCT MADE WITH THE LATEST TECHNOLOGY FOR OSTOMY AND STOMA CARE
* SenSura® Mio features BodyFit technology, an elastic adhesive technology fit for all peristomal body profiles. SINGAPORE, Feb. 9, 2022 /PRNewswire/ -- Coloplast, one of the world's leading manufacturers of stoma care products launches its latest product innovation, the SenSura®Mio in Singapor...
2022-02-09 12:44
2910
Luye Pharma Grants Laboratorio LIBRA Exclusive Marketing Rights for Seroquel and Seroquel XR in Chile
SHANGHAI, Feb. 9, 2022 /PRNewswire/ -- Luye Pharma Group announced today that it has entered into an agreement with Laboratorio LIBRA, under which the company grants Laboratorio LIBRA the exclusive rights to market its innovative CNS (central nervous system) drugs Seroquel (quetiapine fumarate, i...
2022-02-09 11:57
2686
CStone announced new drug approval of China's first IDH1 inhibitor TIBSOVO® (ivosidenib tablets) as a new precision therapy for patients with acute myeloid leukemia
* TIBSOVO®, a first-in-class drug, is approved for adult patients with relapsed/refractory acute myeloid leukemia (R/R AML) who have a susceptible IDH1 mutation * Clinical study data showed that TIBSOVO® had robust clinical efficacy and a well-tolerated and manageable safety profile in Chines...
2022-02-09 11:53
5471
Bugworks Research Inc. secures US$18M Series B1 Funding from Reputed Global Investor Syndicate (The EU, UK, Japan, South Africa & India), led by Lightrock India
This Funding will advance highly differentiated assets in the dual areas of Antimicrobial Resistance (AMR) and Immuno-Oncology (IO) BANGALORE, India, SARATOGA, Calif. and ADELAIDE, Australia, Feb. 9, 2022 /PRNewswire/ -- Bugworks Research, a clinical stage multi-indication therapeutics company, ...
2022-02-09 10:00
11223
Bactiguard presents focused growth strategy and sets new long-term financial targets
STOCKHOLM, Feb. 9, 2022 /PRNewswire/ -- Bactiguard presents new long-term financial targets in connection with the year-end report for 2021. The new financial targets relate to growth and profitability, with annual revenues of at least1 billion SEK and annual EBITDA of at least 400 million SEK in...
2022-02-09 07:27
2700
First Proton Therapy Treatment Delivered in Southeast Asia at Her Royal Highness Princess Maha Chakri Sirindhorn Proton Center, Thailand
BANGKOK, Feb. 9, 2022 /PRNewswire/ -- Varian, a Siemens Healthineers company, today announced that Her Royal Highness Princess Maha Chakri Sirindhorn Proton Center has begun treating patients with its new Varian ProBeam® proton therapy system, the first of its kind inThailand and Southeast Asia. ...
2022-02-09 05:15
5690
Bactiguard and Zimmer Biomet expand global license partnership
STOCKHOLM, Feb. 9, 2022 /PRNewswire/ -- Bactiguard and Zimmer Biomet have today agreed to expand the global license partnership, that was initiated in 2019, to cover multiple product segments. The extended exclusive license agreement covers implants for joint reconstruction (hips and knees), spo...
2022-02-09 04:10
2337
Cambrex Recognized with 2022 CMO Leadership Awards for the 8th Consecutive Year
EAST RUTHERFORD, N.J., Feb. 8, 2022 /PRNewswire/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO), announced today that it has been recognized by the annual CMO (Contract Manufacturing Organization) Leadership Awards in the categories of Quality and Service....
2022-02-08 22:30
3917
WuXi Biologics Statement
SHANGHAI, Feb. 8, 2022 /PRNewswire/ -- We have been made aware of a recent U.S. Commerce Department announcement that two WuXi Biologics (Cayman) subsidiaries inShanghai and Wuxi will be added to the department's "Unverified List" (UVL) on February 8, 2022. We understand that the reason for this a...
2022-02-08 11:08
4194
Week's Top Stories
Most Reposted
Hong Leong Bank Unveils HLB opus Extended Exclusively by Private Invitation
[Picked up by 317 media titles]
2026-09-03 23:53
Agoda Named Official Travel Partner of Eurovision's Inaugural Asian Edition
[Picked up by 312 media titles]
2026-09-02 12:17
Visa Launches Enhanced A2A Protect Innovations to Help Financial Institutions Stop Fraud Before Money Leaves Accounts
[Picked up by 311 media titles]
2026-09-02 08:30Klook Takes Creator Commerce Beyond Influence With Kreator Shops
[Picked up by 307 media titles]
2026-09-01 11:00
DayOne and TNB Explore Up To 1.5 GW of On-Site Power Generation to Advance Malaysia's Energy Resilience and Digital Economy
[Picked up by 292 media titles]
2026-09-01 17:36Most Read
YY Group Enters New Era as YYForce, Expanding AI, Automation and Human-Robot Workforce Strategy; Nasdaq Ticker Changes to "YFOR"
2026-09-01 04:10
8485
Klook Takes Creator Commerce Beyond Influence With Kreator Shops
2026-09-01 11:00
8430
Agoda Named Official Travel Partner of Eurovision's Inaugural Asian Edition
2026-09-02 12:17
8349
